Global Melanoma Diagnostics and Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 115 pages | ID: GE27B59AD0CEN
LP Information

Abstracts

According to this study, the global Melanoma Diagnostics and Therapeutics market size will reach US$ million by 2031.

Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Melanoma Diagnostics and Therapeutics Industry Forecast” looks at past sales and reviews total world Melanoma Diagnostics and Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Melanoma Diagnostics and Therapeutics sales for 2025 through 2031. With Melanoma Diagnostics and Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Melanoma Diagnostics and Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Melanoma Diagnostics and Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Melanoma Diagnostics and Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Melanoma Diagnostics and Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Melanoma Diagnostics and Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Melanoma Diagnostics and Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Melanoma Diagnostics and Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Nodular Melanoma
• Superficial Spreading Melanoma
• Amelanotic Melanoma
• Others

Segmentation by Application:

• Hospital
• Diagnostic Center
• Medical Institution
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Agilent Technologies
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Qiagen
• Roche
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Melanoma Diagnostics and Therapeutics Market Size (2020-2031)
  2.1.2 Melanoma Diagnostics and Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Melanoma Diagnostics and Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Melanoma Diagnostics and Therapeutics Segment by Type
  2.2.1 Nodular Melanoma
  2.2.2 Superficial Spreading Melanoma
  2.2.3 Amelanotic Melanoma
  2.2.4 Others
2.3 Melanoma Diagnostics and Therapeutics Market Size by Type
  2.3.1 Melanoma Diagnostics and Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Melanoma Diagnostics and Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Diagnostic Center
  2.4.3 Medical Institution
  2.4.4 Others
2.5 Melanoma Diagnostics and Therapeutics Market Size by Application
  2.5.1 Melanoma Diagnostics and Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)

3 MELANOMA DIAGNOSTICS AND THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Melanoma Diagnostics and Therapeutics Market Size Market Share by Player
  3.1.1 Global Melanoma Diagnostics and Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Melanoma Diagnostics and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MELANOMA DIAGNOSTICS AND THERAPEUTICS BY REGION

4.1 Melanoma Diagnostics and Therapeutics Market Size by Region (2020-2025)
4.2 Global Melanoma Diagnostics and Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Melanoma Diagnostics and Therapeutics Market Size Growth (2020-2025)
4.4 APAC Melanoma Diagnostics and Therapeutics Market Size Growth (2020-2025)
4.5 Europe Melanoma Diagnostics and Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Melanoma Diagnostics and Therapeutics Market Size by Country (2020-2025)
5.2 Americas Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025)
5.3 Americas Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Melanoma Diagnostics and Therapeutics Market Size by Region (2020-2025)
6.2 APAC Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025)
6.3 APAC Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2020-2025)
7.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025)
7.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Melanoma Diagnostics and Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MELANOMA DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST

10.1 Global Melanoma Diagnostics and Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Melanoma Diagnostics and Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Melanoma Diagnostics and Therapeutics Forecast
  10.1.3 APAC Melanoma Diagnostics and Therapeutics Forecast
  10.1.4 Europe Melanoma Diagnostics and Therapeutics Forecast
  10.1.5 Middle East & Africa Melanoma Diagnostics and Therapeutics Forecast
10.2 Americas Melanoma Diagnostics and Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Melanoma Diagnostics and Therapeutics Forecast
  10.2.2 Canada Market Melanoma Diagnostics and Therapeutics Forecast
  10.2.3 Mexico Market Melanoma Diagnostics and Therapeutics Forecast
  10.2.4 Brazil Market Melanoma Diagnostics and Therapeutics Forecast
10.3 APAC Melanoma Diagnostics and Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Melanoma Diagnostics and Therapeutics Market Forecast
  10.3.2 Japan Market Melanoma Diagnostics and Therapeutics Forecast
  10.3.3 Korea Market Melanoma Diagnostics and Therapeutics Forecast
  10.3.4 Southeast Asia Market Melanoma Diagnostics and Therapeutics Forecast
  10.3.5 India Market Melanoma Diagnostics and Therapeutics Forecast
  10.3.6 Australia Market Melanoma Diagnostics and Therapeutics Forecast
10.4 Europe Melanoma Diagnostics and Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Melanoma Diagnostics and Therapeutics Forecast
  10.4.2 France Market Melanoma Diagnostics and Therapeutics Forecast
  10.4.3 UK Market Melanoma Diagnostics and Therapeutics Forecast
  10.4.4 Italy Market Melanoma Diagnostics and Therapeutics Forecast
  10.4.5 Russia Market Melanoma Diagnostics and Therapeutics Forecast
10.5 Middle East & Africa Melanoma Diagnostics and Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Melanoma Diagnostics and Therapeutics Forecast
  10.5.2 South Africa Market Melanoma Diagnostics and Therapeutics Forecast
  10.5.3 Israel Market Melanoma Diagnostics and Therapeutics Forecast
  10.5.4 Turkey Market Melanoma Diagnostics and Therapeutics Forecast
10.6 Global Melanoma Diagnostics and Therapeutics Forecast by Type (2026-2031)
10.7 Global Melanoma Diagnostics and Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Melanoma Diagnostics and Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Melanoma Diagnostics and Therapeutics Product Offered
  11.1.3 Abbott Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Agilent Technologies
  11.2.1 Agilent Technologies Company Information
  11.2.2 Agilent Technologies Melanoma Diagnostics and Therapeutics Product Offered
  11.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Agilent Technologies Main Business Overview
  11.2.5 Agilent Technologies Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Melanoma Diagnostics and Therapeutics Product Offered
  11.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 Bristol-Myers Squibb
  11.4.1 Bristol-Myers Squibb Company Information
  11.4.2 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Product Offered
  11.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bristol-Myers Squibb Main Business Overview
  11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Eli Lilly
  11.5.1 Eli Lilly Company Information
  11.5.2 Eli Lilly Melanoma Diagnostics and Therapeutics Product Offered
  11.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eli Lilly Main Business Overview
  11.5.5 Eli Lilly Latest Developments
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Information
  11.6.2 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Product Offered
  11.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 GlaxoSmithKline Main Business Overview
  11.6.5 GlaxoSmithKline Latest Developments
11.7 Merck
  11.7.1 Merck Company Information
  11.7.2 Merck Melanoma Diagnostics and Therapeutics Product Offered
  11.7.3 Merck Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Merck Main Business Overview
  11.7.5 Merck Latest Developments
11.8 Novartis
  11.8.1 Novartis Company Information
  11.8.2 Novartis Melanoma Diagnostics and Therapeutics Product Offered
  11.8.3 Novartis Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Novartis Main Business Overview
  11.8.5 Novartis Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Melanoma Diagnostics and Therapeutics Product Offered
  11.9.3 Pfizer Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Qiagen
  11.10.1 Qiagen Company Information
  11.10.2 Qiagen Melanoma Diagnostics and Therapeutics Product Offered
  11.10.3 Qiagen Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Qiagen Main Business Overview
  11.10.5 Qiagen Latest Developments
11.11 Roche
  11.11.1 Roche Company Information
  11.11.2 Roche Melanoma Diagnostics and Therapeutics Product Offered
  11.11.3 Roche Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Roche Main Business Overview
  11.11.5 Roche Latest Developments
11.12 Sanofi
  11.12.1 Sanofi Company Information
  11.12.2 Sanofi Melanoma Diagnostics and Therapeutics Product Offered
  11.12.3 Sanofi Melanoma Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Sanofi Main Business Overview
  11.12.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Melanoma Diagnostics and Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Melanoma Diagnostics and Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nodular Melanoma
Table 4. Major Players of Superficial Spreading Melanoma
Table 5. Major Players of Amelanotic Melanoma
Table 6. Major Players of Others
Table 7. Melanoma Diagnostics and Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Melanoma Diagnostics and Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Melanoma Diagnostics and Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Melanoma Diagnostics and Therapeutics Key Players Head office and Products Offered
Table 16. Melanoma Diagnostics and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Melanoma Diagnostics and Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Melanoma Diagnostics and Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Melanoma Diagnostics and Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Melanoma Diagnostics and Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Melanoma Diagnostics and Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Melanoma Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Melanoma Diagnostics and Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Melanoma Diagnostics and Therapeutics
Table 41. Key Market Challenges & Risks of Melanoma Diagnostics and Therapeutics
Table 42. Key Industry Trends of Melanoma Diagnostics and Therapeutics
Table 43. Global Melanoma Diagnostics and Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Melanoma Diagnostics and Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Melanoma Diagnostics and Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Melanoma Diagnostics and Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Abbott Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 48. Abbott Melanoma Diagnostics and Therapeutics Product Offered
Table 49. Abbott Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Agilent Technologies Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 53. Agilent Technologies Melanoma Diagnostics and Therapeutics Product Offered
Table 54. Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Agilent Technologies Main Business
Table 56. Agilent Technologies Latest Developments
Table 57. AstraZeneca Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 58. AstraZeneca Melanoma Diagnostics and Therapeutics Product Offered
Table 59. AstraZeneca Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca Latest Developments
Table 62. Bristol-Myers Squibb Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Product Offered
Table 64. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Bristol-Myers Squibb Main Business
Table 66. Bristol-Myers Squibb Latest Developments
Table 67. Eli Lilly Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 68. Eli Lilly Melanoma Diagnostics and Therapeutics Product Offered
Table 69. Eli Lilly Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Eli Lilly Main Business
Table 71. Eli Lilly Latest Developments
Table 72. GlaxoSmithKline Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 73. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Product Offered
Table 74. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments
Table 77. Merck Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 78. Merck Melanoma Diagnostics and Therapeutics Product Offered
Table 79. Merck Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Novartis Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 83. Novartis Melanoma Diagnostics and Therapeutics Product Offered
Table 84. Novartis Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Pfizer Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 88. Pfizer Melanoma Diagnostics and Therapeutics Product Offered
Table 89. Pfizer Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Qiagen Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 93. Qiagen Melanoma Diagnostics and Therapeutics Product Offered
Table 94. Qiagen Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Qiagen Main Business
Table 96. Qiagen Latest Developments
Table 97. Roche Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 98. Roche Melanoma Diagnostics and Therapeutics Product Offered
Table 99. Roche Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Roche Main Business
Table 101. Roche Latest Developments
Table 102. Sanofi Details, Company Type, Melanoma Diagnostics and Therapeutics Area Served and Its Competitors
Table 103. Sanofi Melanoma Diagnostics and Therapeutics Product Offered
Table 104. Sanofi Melanoma Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Melanoma Diagnostics and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Melanoma Diagnostics and Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Melanoma Diagnostics and Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Melanoma Diagnostics and Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Type in 2024
Figure 10. Melanoma Diagnostics and Therapeutics in Hospital
Figure 11. Global Melanoma Diagnostics and Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Melanoma Diagnostics and Therapeutics in Diagnostic Center
Figure 13. Global Melanoma Diagnostics and Therapeutics Market: Diagnostic Center (2020-2025) & ($ millions)
Figure 14. Melanoma Diagnostics and Therapeutics in Medical Institution
Figure 15. Global Melanoma Diagnostics and Therapeutics Market: Medical Institution (2020-2025) & ($ millions)
Figure 16. Melanoma Diagnostics and Therapeutics in Others
Figure 17. Global Melanoma Diagnostics and Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Melanoma Diagnostics and Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Melanoma Diagnostics and Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Melanoma Diagnostics and Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Melanoma Diagnostics and Therapeutics Value Market Share by Country in 2024
Figure 26. United States Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Melanoma Diagnostics and Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Melanoma Diagnostics and Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Melanoma Diagnostics and Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Melanoma Diagnostics and Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Melanoma Diagnostics and Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Melanoma Diagnostics and Therapeutics Market Size 2026-2031 ($ millions)